Articles

  • 1 month ago | medicine.washu.edu | Marta Wegorzewska

    Nationally recognized vitreoretinal surgeon leads efforts to apply AI to advance vision research, improve patient care

  • Feb 14, 2025 | medicine.washu.edu | Marta Wegorzewska

    New effort unites vast rare disease network to advance research, therapies

  • Jan 17, 2025 | medicine.washu.edu | Marta Wegorzewska |Brittney Wheeler

    Individuals with sickle cell disease — a chronic illness where misshapen, sticky blood cells clump together, reducing oxygen delivery to organs — are at a higher risk for stroke and resulting cognitive disability. But even in the absence of stroke, many such patients struggle with remembering, focusing, learning and problem solving, among other cognitive problems, with many facing challenges in school and in the workplace.

  • Nov 20, 2024 | medicine.washu.edu | Marta Wegorzewska

    Visit the News Hub Oral immunotherapy shrinks gastrointestinal tumors in mouse study Immunotherapy is a promising treatment that recruits the immune system to help fight cancer, but it has had limited success in gastrointestinal cancers.

  • Nov 20, 2024 | medicalxpress.com | Marta Wegorzewska

    Immunotherapy is a promising treatment that recruits the immune system to help fight cancer, but it has had limited success in gastrointestinal cancers. Now, researchers at Washington University School of Medicine in St. Louis have engineered a probiotic that delivers immunotherapy directly to the gut to shrink tumors in mice, offering a potentially promising oral drug for hard-to-reach cancers. The probiotic cancer treatment, described Nov.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →